Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
2(17%)
Results Posted
100%(6 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_1
1
8%
Ph phase_2
4
33%
Ph phase_4
3
25%
Ph phase_3
3
25%

Phase Distribution

1

Early Stage

4

Mid Stage

6

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
Phase 2Efficacy & side effects
4(36.4%)
Phase 3Large-scale testing
3(27.3%)
Phase 4Post-market surveillance
3(27.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

6 of 9 finished

Non-Completion Rate

33.3%

3 ended early

Currently Active

2

trials recruiting

Total Trials

12

all time

Status Distribution
Active(3)
Completed(6)
Terminated(3)

Detailed Status

Completed6
Active, not recruiting2
Withdrawn2
Enrolling by invitation1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
2
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (9.1%)
Phase 24 (36.4%)
Phase 33 (27.3%)
Phase 43 (27.3%)

Trials by Status

active_not_recruiting217%
enrolling_by_invitation18%
completed650%
withdrawn217%
terminated18%

Recent Activity

2 active trials
Showing 5 of 12
enrolling_by_invitationphase_2

The Effect of Osteoporotic Medications on Vertebral Bone Quality Score

NCT07587775
active_not_recruitingphase_4

Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone

NCT04467983
completedphase_4

Abaloparatide Before Total Knee Arthroplasty

NCT04167163
active_not_recruitingphase_2

Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery

NCT03841058
terminatedphase_2

PTH Analog Type II Odontoid Fracture

NCT04760782
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT07587775Phase 2

The Effect of Osteoporotic Medications on Vertebral Bone Quality Score

Enrolling By Invitation
NCT04467983Phase 4

Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone

Active Not Recruiting
NCT04167163Phase 4

Abaloparatide Before Total Knee Arthroplasty

Completed
NCT03841058Phase 2

Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery

Active Not Recruiting
NCT04760782Phase 2

PTH Analog Type II Odontoid Fracture

Terminated
NCT04626141Phase 4

Supracondylar Distal Femur Fractures and Abaloparatide

Withdrawn
NCT04974723

Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal Women

Completed
NCT03512262Phase 3

Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM)

Completed
NCT04064411Phase 3

Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis

Completed
NCT03746041Phase 1

A Phase I Pilot Study of Abaloparatide + Bevacizumab in Myelodysplastic Syndromes

Completed
NCT03710889Phase 3

Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption

Completed
NCT03708926Phase 2

Effect of Abaloparatide on Lumbar Disc Degeneration

Withdrawn

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12